ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo
Xinyi Xu,1 Yuji Wang,1 Jianhui Wu,1 Xi Hu,1 Haimei Zhu,1 Xiaoyi Zhang,1 Yaonan Wang,1 Lin Gui,1 Ming Zhao,1,2 Shiqi Peng1 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory...
Guardado en:
Autores principales: | Xu X, Wang Y, Wu J, Hu X, Zhu H, Zhang X, Wang YN, Gui L, Zhao M, Peng S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3558bb4ce83c454b89c230f0ea3fefeb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models
por: Feng Q, et al.
Publicado: (2021) -
mRNA expressions of peroxisome proliferator-activated receptor gamma coactivator 1α, tumor necrosis factor-α, and interleukin-6 in paraspinal muscles of patients with lumbar kyphosis: a preliminary study
por: Kudo D, et al.
Publicado: (2018) -
Preparation of W/O Hypaphorine–Chitosan Nanoparticles and Its Application on Promoting Chronic Wound Healing via Alleviating Inflammation Block
por: Mengting Qi, et al.
Publicado: (2021) -
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
por: Wu J, et al.
Publicado: (2018) -
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
por: A. A. Alshevskaya, et al.
Publicado: (2012)